Cargando…
Treatment of Breast Cancer‐Related Lymphedema with Adipose‐Derived Regenerative Cells and Fat Grafts: A Feasibility and Safety Study
Breast cancer‐related lymphedema (BCRL) is a debilitating late complication with a lack of treatment opportunities. Recent studies have suggested that mesenchymal stromal cells can alleviate lymphedema. Herein, we report the results from the first human pilot study with freshly isolated adipose‐deri...
Autores principales: | Toyserkani, Navid Mohamadpour, Jensen, Charlotte Harken, Andersen, Ditte Caroline, Sheikh, Søren Paludan, Sørensen, Jens Ahm |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689749/ https://www.ncbi.nlm.nih.gov/pubmed/28653440 http://dx.doi.org/10.1002/sctm.17-0037 |
Ejemplares similares
-
Adipose‐derived regenerative cells and lipotransfer in alleviating breast cancer‐related lymphedema: An open‐label phase I trial with 4 years of follow‐up
por: Jørgensen, Mads Gustaf, et al.
Publicado: (2021) -
Safety and Potential Effect of a Single Intracavernous Injection of Autologous Adipose-Derived Regenerative Cells in Patients with Erectile Dysfunction Following Radical Prostatectomy: An Open-Label Phase I Clinical Trial
por: Haahr, Martha Kirstine, et al.
Publicado: (2016) -
Concise Review: A Safety Assessment of Adipose‐Derived Cell Therapy in Clinical Trials: A Systematic Review of Reported Adverse Events
por: Toyserkani, Navid Mohamadpour, et al.
Publicado: (2017) -
CD31 defines a subpopulation of human adipose-derived regenerative cells with potent angiogenic effects
por: Dhumale, Pratibha, et al.
Publicado: (2023) -
Adipose-derived stem cells for treatment of chronic ulcers: current status
por: Holm, Jens Selch, et al.
Publicado: (2018)